Back to search

Article

SARS-CoV-2 Omicron potently neutralized by a novel antibody with unique Spike binding properties

2022-03-18

Abstract excerpt

The SARS-CoV-2 Omicron variant exhibits very high levels of transmission, pronounced resistance to authorized therapeutic human monoclonal antibodies and reduced sensitivity to vaccine-induced immunity. Here we describe P2G3, a human monoclonal antibody (mAb) isolated from a previously infected and vaccinated donor, which displays picomolar-range neutralizing activity against Omicron BA.1, BA.1.1, BA.2 and all oth...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
de66a6ab-8050-5dc7-a0fa-5320f5bd000b
DOI
10.1101/2022.03.18.484873
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
SARS-CoV-2 Omicron potently neutralized by a novel antibody with unique Spike binding propertiesDOI 10.1101/2022.03.18.484873
Select a neighboring publication to make it the new centre.